|
|
RESEARCH INTERESTS
Receptors and ion channels, Neuroscience, Neuropharmacology
Modulation of neurotransmitter release
Isolation & biochemical characterization of peptides that target nicotinic acetycholine receptors
Functional structure of conotoxins
Nicotinic receptors in Parkinson's Disease
Development of novel medications
PUBLICATIONS
We are interested in the isolation and biochemical
characterization of compounds that selectively act on
the nervous system. These probes are used to study the
structure and function of central nervous system
receptors and ion channels in both health and disease
states. Structure/function analysis of these ligands
provides opportunity for drug development of selected
compounds. Currently these compounds are being
investigated for the treatment of chronic pain, epilepsy,
cardiovascular disorders and neuropsychiatric
disorders.
Selected Publications
Kulak, J.M., T.A. Nguyen, B.M. Olivera and J.M. McIntosh
(1997) a-Conotoxin MII blocks nicotine-stimulated
dopamine release in rat striatal synaptosomes. J.
Neurosci. 17:5263-70.
Luo, S., J.M. Kulak, G.E. Cartier, R.B. Jacobsen, D.
Yoshikami, B.M. Olivera and J.M. McIntosh (1998) a-
Conotoxin AuIB selectively blocks a3b4 nicotinic
acetylcholine receptors and nicotine-evoked
norepinephrine release. J. Neurosci. 18:8571-79.
McIntosh, J.M., A.D. Santos and B.M. Olivera (1999) Conus
peptides targeted to specific nicotinic acetylcholine
receptor subtypes. Annu. Rev. Biochem. 68:59-88.
Whiteaker, P., J.M. McIntosh, S. Luo, A.C. Collins and M.J.
Marks (2000) 125I-a-Conotoxin MII identifies a
novel
nicotinic acetylcholine receptor population in mouse
brain. Mol. Pharmacol. 57:913-25.
Oppenheim, R.W., D. Prevette, A. D'Costa, S. Wang, L.J.
Houenou and J.M. McIntosh (2000) Reduction of
neuromuscular activity is required for the rescue of
motoneurons from naturally occurring cell death by
nicotinic blocking agents. J. Neurosci. 20:6117-24.
Quik, M., Y. Polonskaya, J.M. Kulak and J.M. McIntosh
(2001) Vulnerability of 125I-a-conotoxin MII
binding sites
to nigrostriatal damage in monkeys. J. Neurosci.21(15):5494-5500.
| |
|
|